Powerful short film drives vital new pulmonary fibrosis awareness campaign

A new short film by pharmaceutical company Boehringer Ingelheim aims to raise awareness of pulmonary fibrosis (PF) in the UAE, where cases are increasing. The film, featured on their social media channels, tells the story of a man with a persistent dry cough who seeks help after being noticed by a young girl and medical professional.

The film highlights the effects of PF, a condition characterized by progressive scarring of the lungs leading to a decline in lung function, which can be fatal if left untreated. Symptoms include shortness of breath, fatigue, and weight loss, and can be mistaken for aging, tiredness, allergies, or other conditions. Boehringer Ingelheim emphasizes the importance of early diagnosis and treatment, as diagnosis can be delayed by one to two years, potentially worsening the condition.

The company's campaign follows the approval of a new treatment option in the UAE, aiming to improve disease management. Dr Bassam Mahboub, vice president of the Emirates Thoracic Society, notes that case numbers are rising due to better detection, with contributors including increased smoking and environmental hazards. Early screening is crucial, especially for people with autoimmune conditions, persistent symptoms, or relevant exposures.

Although PF is rare, it affects up to 9.2 million people globally, and its progressive nature underscores the importance of early intervention.